Trial intelligence / Profile preview

Tiotropium with or without low-dose theophylline in stable COPD

ChiCTR1800019027Phase 4Completed

Sponsor
West China Hospital of Sichuan University
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of tiotropium and theophylline in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: CAT score, mMRC dyspnea score and 1 more. Started Mar 2015; status: completed.

02

Drugs

tiotropiumtheophylline
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on ChiCTR1800019027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800019027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call